BLK
58
-2
HSY
34
-3
NEE
52
-16
EMC
80
20
AXP
66
-4
VFC
72
-7
CMI
75
-2
MRK
58
-2
CCL
58
3
UHS
62
-2
GRMN
42
-3
DHI
33
-6
XEL
39
-4
APH
58
2
DUK
50
-2
UNM
50
-3
DE
42
-3
EMR
67
-3
BSX
54
-5
TAP
37
8
BLK
58
-2
HSY
34
-3
NEE
52
-16
EMC
80
20
AXP
66
-4
VFC
72
-7
CMI
75
-2
MRK
58
-2
CCL
58
3
UHS
62
-2
GRMN
42
-3
DHI
33
-6
XEL
39
-4
APH
58
2
DUK
50
-2
UNM
50
-3
DE
42
-3
EMR
67
-3
BSX
54
-5
TAP
37
8
Financhill
Back

Abits Group, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
28

ABTS
Abits Group, Inc.

Last Price:
$5.92
Seasonality Move:
-4.69%
Buy
90

KYMR
Kymera Therapeutics, Inc.

Last Price:
$94.38
Seasonality Move:
7.7%
Sell
28
Abits Group, Inc. (ABTS) is a Sell

Is Abits Group, Inc. a Buy, Sell or Hold?

  • The current Abits Group, Inc. [ABTS] share price is $5.95. The Score for ABTS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • ABTS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
90
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

ABTS Stock Price Chart

What is Abits Group, Inc.'s stock price today?

  • The Abits Group, Inc. share price today is $5.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABTS is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $94.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

ABTS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 47.36 Sell
Chaikin Money Flow: -6639 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.73 - 6.33) Sell
Bollinger Bands (100): (3.98 - 7.7) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.92 Buy
Relative Strength Index (14 RSI): 86.88 Buy
Chaikin Money Flow: -462379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.8 - 71.72) Buy
Bollinger Bands (100): (43.38 - 63.26) Buy

ABTS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.99 Sell
20-day SMA: 5.99 Sell
50-day SMA: 7.05 Sell
200-day SMA: 4.8 Buy
8-day EMA: 5.98 Sell
20-day EMA: 6.1 Sell
50-day EMA: 6.29 Sell
200-day EMA: 5.9 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70 Buy
20-day SMA: 66.61 Buy
50-day SMA: 61.97 Buy
200-day SMA: 44.25 Buy
8-day EMA: 72.36 Buy
20-day EMA: 67.57 Buy
50-day EMA: 61.93 Buy
200-day EMA: 49.42 Buy

Abits Group, Inc. Earnings Growth & ABTS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.

Abits Group, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):